Essra Ridha - 01 Nov 2021 Form 4 Insider Report for AVROBIO, Inc. (TECX)

Role
Chief Medical Officer
Signature
/s/ Christopher Gerry, Attorney in Fact for Essra Ridha
Issuer symbol
TECX
Transactions as of
01 Nov 2021
Net transactions value
$0
Form type
4
Filing time
02 Nov 2021, 16:59:41 UTC
Previous filing
27 Oct 2021
Next filing
04 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVRO Stock Option (Right to Buy) Award $0 +120,000 $0.000000 120,000 01 Nov 2021 Common Stock 120,000 $5.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares shall vest and become exercisable on November 1, 2022, and the remaining 75% shall vest in equal monthly installments thereafter over a 3 year period.